Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for kids with severe psoriasis?

NCT ID NCT05565560

Ongoing Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

Summary

This study is testing whether the medication apremilast can safely and effectively reduce skin symptoms in Japanese children and teenagers (ages 6-17) who have moderate to severe plaque psoriasis. It involves 17 participants and will measure how much their skin clears up and how their quality of life changes over 16 weeks. The goal is to see if this oral treatment, already used in adults, can help control this chronic skin condition in younger patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Dokkyo Medical University Hospital

    Shimotsuga-gun, Tochigi, 321-0293, Japan

  • Fukuoka University Hospital

    Fukuoka, Fukuoka, 814-0180, Japan

  • Fukushima Medical University Hospital

    Fukushima, Fukushima, 960-1295, Japan

  • Gifu University Hospital

    Gifu, Gifu, 501-1194, Japan

  • Gunma University Hospital

    Maebashi, Gunma, 371-8511, Japan

  • Hokkaido University Hospital

    Sapporo, Hokkaido, 060-8648, Japan

  • Hospital of the University of Occupational and Environmental Health, Japan

    Kitakyushu-shi, Fukuoka, 807-8556, Japan

  • Kanazawa Medical University Hospital

    Kahoku-gun, Ishikawa-ken, 920-0293, Japan

  • Kansai Medical University Hospital

    Hirakata-shi, Osaka, 573-1191, Japan

  • Kindai University Hospital

    Osakasayama-shi, Osaka, 589-8511, Japan

  • Kurume University Hospital

    Kurume-shi, Fukuoka, 830-0011, Japan

  • Mita Dermatology Clinic

    Minato-ku, Tokyo, 108-0014, Japan

  • Nagasaki University Hospital

    Nagasaki, Nagasaki, 852-8501, Japan

  • Nagoya City University Hospital

    Nagoya, Aichi-ken, 467-8602, Japan

  • Nippon Life Hospital

    Osaka, Osaka, 550-0006, Japan

  • Saruwatari Dermatology Clinic

    Kagoshima, Kagoshima-ken, 890-0046, Japan

  • Seibo International Catholic Hospital

    Shinjuku-ku, Tokyo, 161-8521, Japan

  • Shinshu University Hospital

    Matsumoto-shi, Nagano, 390-8621, Japan

  • St Lukes International Hospital

    Chuo-ku, Tokyo, 104-8560, Japan

  • St Marianna University Hospital

    Kawasaki-shi, Kanagawa, 216-8511, Japan

  • Sugai Dermatology Park Side Clinic

    Utsunomiya, Tochigi, 321-0954, Japan

  • Takagi Dermatological Clinic

    Obihiro-shi, Hokkaido, 080-0013, Japan

  • Takamatsu Red Cross Hospital

    Takamatsu, Kagawa-ken, 760-0017, Japan

  • Takeoka Dermatology Clinic

    Marugame-shi, Kagawa-ken, 763-0074, Japan

  • Teikyo University Hospital

    Itabashi-ku, Tokyo, 173-8606, Japan

  • Tokai University Hospital

    Isehara-shi, Kanagawa, 259-1193, Japan

  • Tokyo Medical University Hospital

    Shinjyuku-ku, 160-0023, Japan

  • University Hospital Kyoto Prefectural University of Medicine

    Kyoto, Kyoto, 602-8566, Japan

  • University of the Ryukyus Hospital

    Ginowan-shi, Okinawa, 901-2725, Japan

Conditions

Explore the condition pages connected to this study.

PLAQUE PSORIASIS